We are live on ! Find out more
PLSE icon

Pulse Biosciences

84 hedge funds and large institutions have $91.7M invested in Pulse Biosciences in 2025 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 23 increasing their positions, 29 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

183% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 6

44% more call options, than puts

Call options by funds: $1.49M | Put options by funds: $1.03M

15% more funds holding

Funds holding: 7384 (+11)

0.44% less ownership

Funds ownership: 9.7%9.26% (-0.44%)

12% less capital invested

Capital invested by funds: $104M → $91.7M (-$12.2M)

21% less repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 29

Holders
84
Holders Change
+11
Holders Change %
+15.07%
% of All Funds
1.13%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
17
Increased
23
Reduced
29
Closed
6
Calls
$1.49M
Puts
$1.03M
Net Calls
+$457K
Net Calls Change
-$353K

PLSE Hedge Fund Activity: Q1 2025 in Review

84 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Pulse Biosciences (PLSE) for Q1 2025, worth a combined $91.7M — down 12% from $104M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new PLSE positions and 6 closed out — a net gain of 11 holders — while 23 added to existing stakes and 29 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $1.61M. The largest seller was Vanguard Group, cutting an estimated $5.65M.

  • 84 institutional investors held Pulse Biosciences (PLSE) as of Q1 2025, up from 73 in Q4 2024.
  • Funds reported $91.7M of Pulse Biosciences stock for Q1 2025, down 12% quarter-over-quarter.
  • 17 funds opened new Pulse Biosciences positions in Q1 2025 and 6 closed out, a net change of +11 holders.
  • The largest Pulse Biosciences buyer in Q1 2025 was Millennium Management, an estimated $1.61M added.
  • The largest Pulse Biosciences seller in Q1 2025 was Vanguard Group, an estimated $5.65M sold.

Based on aggregated 13F filings for Q1 2025.